Title: | Hoffbrand's essential haematology. |
Author Name: | A. V. Hoffbrand and Paul A. H. Moss. |
Author Sur Name: | HOFFBRAND, A. V. |
Author information: |
|
Edition/Published: | 7th ed. _Chichester : Wiley Blackwell , 2016 |
New to this edition: |
|
Physical Description: : <p>ix, 369p.: Illustration, Diagramme, 27cm.</p>.; |
Notes | Includes index. |
Includes Index: | 357-370 |
ISBN No's: | 978-1-118-40867-4 |
Bar Code's: | |
Shelf Location's: |
Classification | |
Subject: | Blood Diseases |
Dewey Class No: | 616.15 |
LC Classification: | RC633 |
Other's Book Information | |
Book ID No: | 1957 |
Total Books: | 1 |
Date of collection's: | 29-Jan-2017 |
Language: | English |
Status: | Available |
Department: | Pathology |
Synopsis: |
|
Review: |
|
Description: |
|
Key Features: |
|
Summary: |
The 7th edition of "Hoffbrand's Essential Haematology" is a comprehensive and authoritative textbook on the fundamental principles of hematology. The book covers five main sections, including the basics of hematology, red blood cell disorders, white blood cell, and lymphoid disorders, hemostasis and thrombosis, transfusion medicine, and hematopoietic stem cell transplantation. This new edition is extensively revised and updated to reflect the latest research and advancements in the field, including two new chapters and additional sections covering genomic and genetic advances in hematology. The book also includes self-assessment questions, animations, and case studies to help students deepen their understanding of the material. Hoffbrand's Essential Hematology, 7th edition is a valuable resource for students, trainees, and practitioners in the field of hematology, providing a comprehensive and clinically relevant overview of the subject. |
Abstract: |
Hoffbrand's Essential Hematology, 7th edition provides a comprehensive overview of the field of hematology, covering both basic science and clinical aspects. The book is divided into five sections, starting with an introduction to the blood and hematopoietic system, followed by sections on red blood cell disorders, white blood cell disorders, hemostasis and thrombosis, and finally, neoplastic disorders of the blood and bone marrow. The seventh edition includes several updates and additions compared to the sixth edition, reflecting the latest advances in research and clinical practice. These updates include advances in the understanding of the genetic basis of hematological disorders, updates to the classification and management of hematological disorders, and expanded coverage of the role of the bone marrow microenvironment in the pathogenesis of hematological disorders. The book also includes new chapters on the use of laboratory tests in the diagnosis and management of hematological disorders, and on the role of the spleen in hematological disorders. Throughout the book, there is an emphasis on the clinical relevance of the material, with numerous case studies, clinical examples, and illustrations to aid understanding. Overall, Hoffbrand's Essential Hematology, 7th edition is a valuable resource for students, trainees, and practitioners in the field of hematology, providing a comprehensive and up-to-date overview of the subject. |
Preface: |
There have been remarkable advances in the understanding of the pathogenesis of diseases of the blood and lymphatic system and in the treatment of these diseases since the 6th Edition of Essential Haematology was published in 2011. This new knowledge is due largely to the application of next-generation sequencing of DNA which has enabled the detection of the genetic mutations, inherited or acquired, that underlie these diseases. As an example, sequencing has revealed the CALR mutation underlying a substantial proportion of patients with myeloproliferative diseases and the MYD88 mutation present in almost all cases of Waldenstrom’s macroglobulinaemia. Multiple ‘driver’ gene mutations affecting signalling pathways and epigenetic reactions involved in cell proliferation and survival have been discovered which underlie myelodysplasia, acute myeloid and lymphoblastic leukaemias, chronic lymphocytic leukaemia and lymphomas. The complexity of the molecular changes underlying malignant diseases and the relevance of this to their sensitivity or resistance to therapy is becoming apparent. This new knowledge has been accompanied by spectacular improvements in therapy. Inhibition of the B cell receptor signalling pathway has transformed the life expectancy in many patients with resistant chronic lymphocytic leukaemia and some of the B cell lymphomas resistant to other therapy. JAK2 inhibitors are improving the quality of life and survival in primary myelofibrosis. Survival in myeloma is improving remarkably with new proteasome inhibitory and immunomodulatory drugs. Life expectancy has also improved for patients with diseases such as thalassaemia major receiving multiple transfusions with the worldwide introduction of orally active iron chelating agents. New anticoagulants which directly inhibit at a single point in the coagulation cascade and rarely need monitoring are now used commonly in preference to warfarin for the treatment and prevention of arterial and venous thrombosis. These advances in knowledge have been incorporated as new text, diagrams and tables for this seventh edition. New multiple-choice questions have been added to the website and short summary boxes are included at the end of each chapter. We thank Dr Trevor Baglin for his helpful suggestions for the coagulation section of the book. We wish to thank our publishers Wiley‐Blackwell and the staff who have helped us with the production of this 7th Edition. We also thank Jane Fallows for once more producing clear, expertly drawn scientific diagrams. We hope it will be widely used both by undergraduates and by postgraduates in medicine and related sciences wishing to gain a grounding in one of the most exciting and advanced fields of medicine.
Victor Hoffbrand Paul Moss |
Content: |
Preface to the Seventh Edition Preface to the First Edition vii How to use your textbook viii About the companion website x 1. Haemopoiesis-1 2. Erythropoiesis and general aspects of Anaemia-11 3. Hypochromic anaemias-27 4. Iron overload-41 5. Megaloblastic anaemias and other macrocytic anaemias-48 6. Haemolytic anaemias-60 7. Genetic disorders of haemoglobin-72 8. The white cells 1: granulocytes, monocytes and their benign disorders-87 9. The white cells 2: lymphocytes and their benign disorders-102 10. The spleen-116 11. The aetiology and genetics of haematological malignancies-122 12. Management of haematological malignancy-135 13. Acute myeloid leukaemia-145 14. Chronic myeloid leukaemia-156 15. Myeloproliferative disease-165 16. Myelodysplasia-177 17. Acute lymphoblastic leukaemia-186 18. The chronic lymphoid leukaemias-197 19. Hodgkin lymphoma-205 20. Non-Hodgkin lymphoma-213 21. Multiple myeloma and related disorders-228 22. Aplastic anaemia and bone marrow failure-242 23. Stem cell transplantation-250 24. Platelets, blood coagulation and haemostasis-264 25. Bleeding disorders caused by vascular and platelet abnormalities-278 26. Coagulation disorders-290 27. Thrombosis 1: pathogenesis and diagnosis-302 28. Thombosis 2: treatment-311 29. Haematological changes in systemic disease-321 30. Blood transfusion-333 31. Pregnancy and neonatal haematology-346 Appendix: World Health Organization classification of tumours of the haematopoietic and lymphoid tissues-352 Index 357 |